Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Cancer Treatment Reports
|
March 1, 1985
Supporting evidence for an active treatment program for advanced salivary gland carcinomas
M A Eisenberger
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1988
Chemotherapy for prostate carcinoma
M A Eisenberger
The Urologic Clinics of North America
|
May 1, 1992
Chemotherapy for carcinomas of the penis and urethra
M A Eisenberger
Progress in Clinical and Biological Research
|
January 1, 1990
Chemotherapy for endocrine resistant cancer of the prostate
M A Eisenberger
The New England Journal of Medicine
|
December 10, 1999
Early androgen deprivation for prostate cancer?
M A Eisenberger, P C Walsh
Cancer Treatment Reviews
|
July 1, 1994
Suramin
M A Eisenberger, L M Reyno
Journal of the National Cancer Institute
|
January 1, 1992
Suramin, an active nonhormonal cytotoxic drug for treatment of prostate cancer: compelling reasons for testing in patients with hormone-refractory breast cancer
M A Eisenberger, J A Fontana
Journal of the National Cancer Institute
|
June 19, 1996
How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution!
M A Eisenberger, W G Nelson
Cancer Treatment Reports
|
October 1, 1985
An efficient design for phase III studies of combination chemotherapies
S S Ellenberg, M A Eisenberger
Seminars in Urology
|
November 1, 1988
Chemotherapy for prostatic carcinoma
M A Eisenberger, J S Abrams
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Cancer Treatment Reports
|
March 1, 1985
Supporting evidence for an active treatment program for advanced salivary gland carcinomas
M A Eisenberger
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1988
Chemotherapy for prostate carcinoma
M A Eisenberger
The Urologic Clinics of North America
|
May 1, 1992
Chemotherapy for carcinomas of the penis and urethra
M A Eisenberger
Progress in Clinical and Biological Research
|
January 1, 1990
Chemotherapy for endocrine resistant cancer of the prostate
M A Eisenberger
The New England Journal of Medicine
|
December 10, 1999
Early androgen deprivation for prostate cancer?
M A Eisenberger, P C Walsh
Cancer Treatment Reviews
|
July 1, 1994
Suramin
M A Eisenberger, L M Reyno
Journal of the National Cancer Institute
|
January 1, 1992
Suramin, an active nonhormonal cytotoxic drug for treatment of prostate cancer: compelling reasons for testing in patients with hormone-refractory breast cancer
M A Eisenberger, J A Fontana
Journal of the National Cancer Institute
|
June 19, 1996
How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution!
M A Eisenberger, W G Nelson
Cancer Treatment Reports
|
October 1, 1985
An efficient design for phase III studies of combination chemotherapies
S S Ellenberg, M A Eisenberger
Seminars in Urology
|
November 1, 1988
Chemotherapy for prostatic carcinoma
M A Eisenberger, J S Abrams
Page
of 7